Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Neuropsychological Dysfunction among HIV Infected Drug Abusers.

Durvasula RS, Hinkin CH.

Am J Infect Dis. 2006;2(2):67-73.

2.

Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine.

Cherner M, Letendre S, Heaton RK, Durelle J, Marquie-Beck J, Gragg B, Grant I; HIV Neurobehavioral Research Center Group..

Neurology. 2005 Apr 26;64(8):1343-7.

PMID:
15851720
4.
5.

Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance.

Kumar AM, Ownby RL, Waldrop-Valverde D, Fernandez B, Kumar M.

J Neurovirol. 2011 Feb;17(1):26-40. doi: 10.1007/s13365-010-0003-4.

PMID:
21165787
6.

The impact of neuropsychological functioning and depressed mood on functional complaints in HIV-1 infection and methamphetamine dependence.

Sadek JR, Vigil O, Grant I, Heaton RK; HNRC Group..

J Clin Exp Neuropsychol. 2007 Apr;29(3):266-76.

PMID:
17454347
7.

Effects of hepatic function and hepatitis C virus on the nervous system assessment of advanced-stage HIV-infected individuals.

Morgello S, Estanislao L, Ryan E, Gerits P, Simpson D, Verma S, DiRocco A, Sharp V; Manhattan HIV Brain Bank..

AIDS. 2005 Oct;19 Suppl 3:S116-22.

PMID:
16251806
8.

The neuropsychological profile of symptomatic AIDS and ADC patients in the pre-HAART era: a meta-analysis.

Cysique LA, Maruff P, Brew BJ.

J Int Neuropsychol Soc. 2006 May;12(3):368-82.

9.

Neuropsychological functioning in HIV-positive African-American women with a history of drug use.

Mason KI, Campbell A, Hawkins P, Madhere S, Johnson K, Takushi-Chinen R.

J Natl Med Assoc. 1998 Nov;90(11):665-74.

10.

Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain.

Flora G, Lee YW, Nath A, Hennig B, Maragos W, Toborek M.

Exp Neurol. 2003 Jan;179(1):60-70.

PMID:
12504868
11.

Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India.

Gupta JD, Satishchandra P, Gopukumar K, Wilkie F, Waldrop-Valverde D, Ellis R, Ownby R, Subbakrishna DK, Desai A, Kamat A, Ravi V, Rao BS, Satish KS, Kumar M.

J Neurovirol. 2007 Jun;13(3):195-202.

PMID:
17613709
12.

The impact of HIV-associated neuropsychological impairment on everyday functioning.

Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, McCutchan JA, Reicks C, Grant I; HNRC Group..

J Int Neuropsychol Soc. 2004 May;10(3):317-31.

PMID:
15147590
13.

Progress in understanding basal ganglia dysfunction as a common target for methamphetamine abuse and HIV-1 neurodegeneration.

Theodore S, Cass WA, Nath A, Maragos WF.

Curr HIV Res. 2007 May;5(3):301-13. Review.

PMID:
17504172
14.

"Frontal systems" behaviors in comorbid human immunodeficiency virus infection and methamphetamine dependency.

Marquine MJ, Iudicello JE, Morgan EE, Brown GG, Letendre SL, Ellis RJ, Deutsch R, Woods SP, Grant I, Heaton RK; Translational Methamphetamine AIDS Research Center (TMARC) Group..

Psychiatry Res. 2014 Jan 30;215(1):208-16. doi: 10.1016/j.psychres.2013.11.004.

15.

Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection.

Parsons TD, Tucker KA, Hall CD, Robertson WT, Eron JJ, Fried MW, Robertson KR.

AIDS. 2006 Aug 1;20(12):1591-5.

PMID:
16868439
16.

Neuropsychiatric disturbance is associated with executive dysfunction in HIV-1 infection.

Castellon SA, Hinkin CH, Myers HF.

J Int Neuropsychol Soc. 2000 Mar;6(3):336-47.

PMID:
10824505
17.

The effect of recent stimulant use on sustained attention in HIV-infected adults.

Levine AJ, Hardy DJ, Miller E, Castellon SA, Longshore D, Hinkin CH.

J Clin Exp Neuropsychol. 2006 Jan;28(1):29-42.

PMID:
16448974
18.
19.

Additive deleterious effects of methamphetamine dependence and immunosuppression on neuropsychological functioning in HIV infection.

Carey CL, Woods SP, Rippeth JD, Gonzalez R, Heaton RK, Grant I.

AIDS Behav. 2006 Mar;10(2):185-90.

PMID:
16477511
20.

Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients.

Ma Q, Vaida F, Wong J, Sanders CA, Kao YT, Croteau D, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, Morgello S, Simpson DM, Heaton RK, Grant I, Letendre SL; CHARTER Group..

J Neurovirol. 2016 Apr;22(2):170-8. doi: 10.1007/s13365-015-0382-7.

PMID:
26407716
Items per page

Supplemental Content

Support Center